Member Info for Toyin

Oleric, you say you will consider adding to your £10,000 investment, but then go on to say you aren’t a subscriber because you can’t afford £35, what a muppet! Then you ask subscribers to steal from Elric and publish his work, what a moron! Oh, the boxes come with 28 sachets in them, so unless you bought two boxes and threw 26 sachets away you are also a liar. Grow up and get a life, same goes for you nick.

nick, you said, "So all you people that say anyone can get questions answered without relying on Elric or share prophets are wrong." that is factually incorrect. Therefor it wasn't an unfair criticism.

Clio, nick isn't right, he never said the process needs work, he said if you aren't Elric or ************* you dont get a reply. That is totally different.

nick, I can only go on my experience and I have always got a reply. So your statement about us all being wrong is factually incorrect. What was your question?

I am also a shareholder not a troll.

Thank you for pointing me in the right direction, most helpful. :-)

Yes please, can you tell me where the Sbtx thread is? ;-)

Wrong thread guys.

oleric, we may not agree on much, but SA getting abuse is totally unacceptable and whoever it is should be utterly ashamed. On that we agree, well said.

nick, you need to get over yourself. You seriously think investor relations pick and choose who they reply to. FFS, it’s like being in a playground. Seriously, tell me what your question is nick, I will ask it for you, I must be one of the privileged few!

lord, do you ever watch presentations or interviews like investor meet or proactive, of course you do, but all the information is in the public domain, so why bother?

Elric was very kindly going to release the podcast for everybody to listen, but after all the moaning and whinging I have spoke to him this morning and politely requested he doesn't. As there is no point to it anyway as far as you are concerned, no one is missing out. I might also email IR and request they stop wasting money on Investor meet, proactive etc because all the information is already in the public domain, so there is no point to them either. See how stupid your theory sounds!

anon, you are a clown, and anyone who recommended your post is also a clown. Everyone has access if they spend £35! What about SCSW, or ************* as examples, they speak to CEO’s and they are behind paywalls, it’s called a business model. As I say, everyone has access but some choose to deny themselves. If you begrudge £35 for some research you shouldn’t be in the stock market. There is nothing in the interview that isn’t in the public domain so what is the complaint, there is none?

Very true Clio.

elrico, you are wasting your time, Mr Ashman put to bed all the questions and fears in the RNS/podcast yesterday, and now we have some moaning about something else, you cant win! He will be wearing the wrong coloured tie next! Some people just love to moan and talk shyte!

Inside your head must be like a bowl of spaghetti!

sounds, I think you may find this could be huge for Croda not small change, it could in time retire Matrixyl.

Through the course of the collaboration, Sederma continues to identify additional potential scientific and marketing claims for the end ingredient. In parallel to the manufacturing scale-up process that Croda are progressing at its facility near Widnes, Sederma is continuing its lab work to further substantiate any additional potential claims.

Croda has engaged with its VIP clients and management continues to anticipate licensed royalty revenue generation by the end of 2022.

belgrano, who knows, thats just the market, everyone is free to come and go as they please. What do you mean regarding Croda, can you be more specific?

Great chat Elric, thank you. Good to hear the ceo and good to see it puts the order numbers argument to bed.

Trader, thats what TW said in Bearcast earlier today but SA seems to think otherwise. We will get a TR1 if they have.

What does Nimrod mean insult?
(lowercase)Slang. a foolish or inept person; doofus: What an annoying nimrod he turned out to be.

Sounds about right!

Dire, I agree. I want minimum 50p by end of 2022 and I would be disappointed at that.

13 June 2022

SkinBioTherapeutics plc

Share price movement

The Board of SkinBioTherapeutics plc ( AIM: SBTX or the "Company") notes the recent share price movement and confirms that it is not aware of any material commercial or operational reason that might be the cause.

The Company's position on sales of its first commercial product AxisBiotix-Ps(R) was outlined in the Interim Results dated 29 March 2022 where management acknowledged slower uptake than originally anticipated, and that it was not possible to predict the quantum impact on sales.

The team continues to focus on driving sales of AxisBiotix-Ps(R). The marketing and advertising campaign is now very active, using influencers who have psoriasis themselves for the digital campaign and advertising in regional and national newspapers such as the Mail, Telegraph and Metro. The product continues to receive very positive customer feedback and the subscriber retention rate is now >80%.

Other pillars of the business, including work with Croda/Sederma are progressing accordingly to plan.

As always, the Company will continue to inform the market should there be additional news flow.